<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药物简讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-10T20:22:43+08:00</updated>
  <subtitle>【国内外药讯，医药市场，医药数据分享】</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>孙飘扬的恒瑞医药向其母校中国药科大学捐赠1500万元</title>
    <updated>2020-11-10T17:01:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/4MtRc8i0VvzgqCkNL_alLA</id>
    <link href="https://mp.weixin.qq.com/s/4MtRc8i0VvzgqCkNL_alLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature Reviews Drug Discovery：中国肿瘤新药发展概述</title>
    <updated>2020-11-10T17:01:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/xvjEFrmae5JmEpssuvoHuA</id>
    <link href="https://mp.weixin.qq.com/s/xvjEFrmae5JmEpssuvoHuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成都赜灵生物引进5款创新药，NLRP3抑制剂、RIP1/2抑制剂等值得关注</title>
    <updated>2020-11-09T15:17:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/_5hFjAhOvt3HttXlP5rf-Q</id>
    <link href="https://mp.weixin.qq.com/s/_5hFjAhOvt3HttXlP5rf-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Hengenix Biotech宣布ACE2-Fc 受体融合蛋白获FDA批准临床</title>
    <updated>2020-11-09T15:17:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/gd3SE_E-rIaylJtlX9oSmw</id>
    <link href="https://mp.weixin.qq.com/s/gd3SE_E-rIaylJtlX9oSmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>前有千鼠万抗，后有千靶万苗</title>
    <updated>2020-11-08T10:02:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/xGQGPN4Iv5wL-Rxakq0Ckg</id>
    <link href="https://mp.weixin.qq.com/s/xGQGPN4Iv5wL-Rxakq0Ckg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达：恩莎替尼即将获批</title>
    <updated>2020-11-08T10:02:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/frxO4xttu9vgbUA6HkqBEg</id>
    <link href="https://mp.weixin.qq.com/s/frxO4xttu9vgbUA6HkqBEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州：PD-1今年3季度大卖3.31亿，全年破10亿</title>
    <updated>2020-11-06T16:07:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/4Gk-dWMivD6Xmhg-pJxuDw</id>
    <link href="https://mp.weixin.qq.com/s/4Gk-dWMivD6Xmhg-pJxuDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药：勃起功能障碍改良新药悄然获准临床</title>
    <updated>2020-11-06T16:07:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/gd5t8D5qLT8lWWg8yrjSHw</id>
    <link href="https://mp.weixin.qq.com/s/gd5t8D5qLT8lWWg8yrjSHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进博会首日阿斯利康与海南省政府签署战略合作协议</title>
    <updated>2020-11-05T17:37:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/FcDTO2MPo1XEoALWbrr1dQ</id>
    <link href="https://mp.weixin.qq.com/s/FcDTO2MPo1XEoALWbrr1dQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>九洲药业：拟投资16亿元建设大小分子CDMO及制剂基地项目</title>
    <updated>2020-11-05T17:37:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/ZNkOlwEDCWSlnRr4g-B69w</id>
    <link href="https://mp.weixin.qq.com/s/ZNkOlwEDCWSlnRr4g-B69w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达谨慎：终止重金引进的JAK抑制剂急性移植物抗宿主病临床</title>
    <updated>2020-11-04T14:41:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/7R0sE2JYhVr4fL5mX24ntQ</id>
    <link href="https://mp.weixin.qq.com/s/7R0sE2JYhVr4fL5mX24ntQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恩格列净：化合物专利在中国竟然被无效</title>
    <updated>2020-11-04T14:41:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Dztcb-F42Uvaqrz1DUu4Bg</id>
    <link href="https://mp.weixin.qq.com/s/Dztcb-F42Uvaqrz1DUu4Bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明巨诺今日登陆港股上市！</title>
    <updated>2020-11-03T13:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/NO6R9-OVg_c9uJ6sGHjuxg</id>
    <link href="https://mp.weixin.qq.com/s/NO6R9-OVg_c9uJ6sGHjuxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优锐医药5300万美元引进NTM-001镇痛药中国区权益</title>
    <updated>2020-11-03T13:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/UZ4xdnajRNMc7pkm18TnNQ</id>
    <link href="https://mp.weixin.qq.com/s/UZ4xdnajRNMc7pkm18TnNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康提交卡博替尼片上市申请</title>
    <updated>2020-11-03T13:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/_wlG3c5Zj1c-RgXyE5DMXw</id>
    <link href="https://mp.weixin.qq.com/s/_wlG3c5Zj1c-RgXyE5DMXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康开发的注射用泮托拉唑首家过一致性评价</title>
    <updated>2020-11-03T13:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/AlzvhovIxgxCGXh9W3_g7g</id>
    <link href="https://mp.weixin.qq.com/s/AlzvhovIxgxCGXh9W3_g7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明巨诺11月3日香港上市，第一天是涨是跌？</title>
    <updated>2020-11-01T19:22:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/elBd2ODRgPKb0yQ0aX2j9w</id>
    <link href="https://mp.weixin.qq.com/s/elBd2ODRgPKb0yQ0aX2j9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国最强CRO，2020前3季度大增长</title>
    <updated>2020-11-01T19:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/zfvtM20T4krG3Z7Q3_8LGQ</id>
    <link href="https://mp.weixin.qq.com/s/zfvtM20T4krG3Z7Q3_8LGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国投出手大，这次共同领投美资 -联拓生物</title>
    <updated>2020-10-30T15:40:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/r20Fux1U3-G6_3i9eJtQEQ</id>
    <link href="https://mp.weixin.qq.com/s/r20Fux1U3-G6_3i9eJtQEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>